Item

Longitudinal change in CT derived bone mineral density (BMD) in men with M0 prostate cancer treated with androgen receptor pathway inhibitors (ARPI): A sub-analysis of the STAMPEDE trial

Gray, S.
; 
Connock, E.
; 
McSweeney, D.
; 
Jones, C.
; 
Brown, M.
; 
Li, X.
; 
Dallara, E.
; 
Brown, L.
; 
Attard, G.
; 
James, N.
... show 2 more
Citations
Altmetric:
Abstract
Authors
Gray, S.
Connock, E.
McSweeney, D.
Jones, C.
Brown, M.
Li, X.
Dallara, E.
Brown, L.
Attard, G.
James, N.
Clark, N.
Sachdeva, A.
Affiliation
Christie & Salford Royal NHS Fdn Trusts, Dept Urol, Manchester, England Univ Manchester, Div Canc Sci, Genito Urinary Canc Res Grp, Manchester, England Univ Manchester, Radiotherapy Related Res Dept, Div Canc Sci, Manchester, Lancs, England Christie NHS Fdn Trust, Dept Urol, Manchester, England
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Gray S, Connock E, McSweeney D, Jones C, Brown M, Li X, et al. Longitudinal change in CT derived bone mineral density (BMD) in men with M0 prostate cancer treated with androgen receptor pathway inhibitors (ARPI): A sub-analysis of the STAMPEDE trial. EUROPEAN UROLOGY. 2025 MAR;87. PubMed PMID: WOS:001578717000004. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627870
Embedded videos